Cara Therapeutics Inc (CARA)
0.3065
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 15:20
Cara Therapeutics Profit Margin (Quarterly): -488.1% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -488.1% |
June 30, 2024 | -2.02K% |
March 31, 2024 | -1.44K% |
December 31, 2023 | -1.08K% |
September 30, 2023 | -576.1% |
June 30, 2023 | -454.0% |
March 31, 2023 | -432.5% |
December 31, 2022 | -930.4% |
September 30, 2022 | -214.4% |
June 30, 2022 | -18.28% |
March 31, 2022 | -579.3% |
December 31, 2021 | -4.07K% |
September 30, 2021 | -5.00% |
June 30, 2021 | |
March 31, 2021 | -1.20K% |
December 31, 2020 | 70.40% |
September 30, 2020 | -178.2% |
June 30, 2020 | -444.9% |
March 31, 2020 | -357.4% |
December 31, 2019 | -634.2% |
September 30, 2019 | -567.7% |
June 30, 2019 | -440.9% |
March 31, 2019 | -501.1% |
Date | Value |
---|---|
December 31, 2018 | -373.3% |
September 30, 2018 | -383.2% |
June 30, 2018 | -598.3% |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | -2.44K% |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | -16.55K% |
March 31, 2016 | -152.7K% |
December 31, 2015 | |
September 30, 2015 | -196.2% |
June 30, 2015 | -650.3% |
March 31, 2015 | -958.9% |
December 31, 2014 | -456.5% |
September 30, 2014 | -581.8% |
June 30, 2014 | -379.7% |
March 31, 2014 | -1.90K% |
December 31, 2013 | -215.1% |
September 30, 2013 | -449.4% |
June 30, 2013 | 53.51% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.07K%
Minimum
Dec 2021
70.40%
Maximum
Dec 2020
-791.9%
Average
-488.1%
Median
Sep 2024
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
Return on Equity | -258.4% |
Return on Assets | -104.9% |
Return on Invested Capital | -258.4% |
Operating Margin (Quarterly) | -206.6% |
Return on Net Operating Assets | -506.4% |